Interview with Amy Gleason, COO of CareSync

Interview with Amy Gleason, COO of CareSync

We recently sat down with Amy Gleason, COO of CareSync and newly named White House Precision Medicine 'Champion of Change' to find out how she and her company are disrupting the healthcare system with a mix of technology and patient advocacy. Here's what she had...

read more
Understanding Sarcoma

Understanding Sarcoma

Updated June 25, 2019 What is sarcoma? Sarcoma is a group of cancers that often start in the soft tissue or bone. Soft tissue is composed of fat, blood vessels, nerves, muscles, deep skin tissues, and cartilage. What are the types of sarcomas? Soft tissue sarcoma and...

read more
21st Century Cures Act Approved by House of Representatives

21st Century Cures Act Approved by House of Representatives

On July 10, 2015, the House of Representatives approved the 21st Century Cures Act (H.R. 6) with a vote of 344-77. This act will launch healthcare into the 21st century by "investing in science and medical innovation, incorporating the patient perspective, and...

read more
Precision Medicine Champions of Change Honored at White House

Precision Medicine Champions of Change Honored at White House

Last week the White House recognized nine Precision Medicine "Champions of Change" who were selected for their work to advance the goals set out by the President's Precision Medicine Initiative (PMI). The PMI aims to make using a tailored treatment approach for...

read more
Discussion: Precision Medicine Initiative

Discussion: Precision Medicine Initiative

In the words of the National Institute of Health, precision medicine is an approach to disease treatment and prevention that accounts for individual variability in genes, environment and lifestyle. In simpler terms, precision medicine means using a tailored treatment...

read more
GINA Put To the Test

GINA Put To the Test

Updated May 3, 2019 What would really happen if an employer or health insurance company tried to improperly use genetic information? Has GINA ever been tested? Yes.  GINA was put to test when two warehouse workers were awarded $2,225,000 in 2015 because their company,...

read more
Discussion: Men and Hereditary Cancer

Discussion: Men and Hereditary Cancer

In honor of Men’s Health Month and Father’s Day, we wanted to shine a light on an important issue that does not usually get much attention: men and hereditary cancer. Men are often told that they don’t need genetic testing, since the cancer risks only impact women....

read more
The Days of Cookie Cutter Medicine Are Over

The Days of Cookie Cutter Medicine Are Over

Geneticists have long had visions of a future in which medicine would be customized based on each individual's genetic makeup. But the reality of tailoring treatment based on genetic testing has been a complex, expensive and ethically grey area, and science,...

read more

Tips For Having Sex After Oophorectomy, Hysterectomy

A major issue for female cancer previvors and survivors that have undergone an oophorectomy or hysterectomy is sex following surgery. And as you may expect, it’s an issue that patients and clinicians don’t always know how to talk about or address. This...

read more